Literature DB >> 23140203

Osteoporosis healthcare disparities in postmenopausal women.

Irene Hamrick1, Qing Cao, Dorothy Agbafe-Mosley, Doyle M Cummings.   

Abstract

BACKGROUND: Previous studies in referral populations have shown that fewer African American women complete dual-energy x-ray absorptiometry (DXA) screening and are prescribed medications for osteoporosis. This study examines if these disparities exist in primary care practices.
METHODS: Of 4748 eligible women ≥60 years of age in primary care practices, we randomly selected 500 African American and 500 Caucasian women. We compared the DXA screening referral rate and results, follow-up rate, and medication prescribing for low bone mineral density (BMD) between African American and Caucasian women and analyzed provider demographics. We used logistic regression analysis to control confounding variables, such as age and BMI.
RESULTS: Among the initial 1000 women, only 29.8% African American Women were referred to DXA compared to 38.4% Caucasian women (p<0.05), and 20.8% African American vs. 27.0% Caucasian (p<0.05) women completed the test. Among women with a diagnosis of osteoporosis, African Americans were less likely to receive medication (79.6% vs. 89.2%, p<0.05), without a difference in follow-up visit pattern between races. Female providers were more likely to refer women for DXA (27.7%) than male providers (21.7%) (p=0.035), and this gender difference in referral was more pronounced for African American patients.
CONCLUSIONS: Not enough eligible women are being screened and treated for osteoporosis in primary care. Even fewer African American women receive DXA screenings and are treated for osteoporosis. Controlling for age and BMI attenuated but did not eliminate the difference. Female providers were more likely than male providers to refer women for DXA.

Entities:  

Mesh:

Year:  2012        PMID: 23140203      PMCID: PMC3518540          DOI: 10.1089/jwh.2012.3812

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  19 in total

1.  ACOG releases guidelines for clinical management of osteoporosis.

Authors:  Matthew J Neff
Journal:  Am Fam Physician       Date:  2004-03-15       Impact factor: 3.292

2.  Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry.

Authors:  S M Cadarette; S B Jaglal; T M Murray; W J McIsaac; L Joseph; J P Brown
Journal:  JAMA       Date:  2001-07-04       Impact factor: 56.272

3.  Validation of the simple calculated osteoporosis risk estimation (SCORE) for patient selection for bone densitometry.

Authors:  S M Cadarette; S B Jaglal; T M Murray
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

Review 4.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1994

5.  Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry.

Authors:  S M Cadarette; S B Jaglal; N Kreiger; W J McIsaac; G A Darlington; J V Tu
Journal:  CMAJ       Date:  2000-05-02       Impact factor: 8.262

6.  Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study.

Authors:  Kevin P Chang; Jacqueline R Center; Tuan V Nguyen; John A Eisman
Journal:  J Bone Miner Res       Date:  2004-01-05       Impact factor: 6.741

7.  Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group.

Authors:  S R Cummings; D M Black; M C Nevitt; W Browner; J Cauley; K Ensrud; H K Genant; L Palermo; J Scott; T M Vogt
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

8.  Factors influencing adherence to guidelines for screening mammography among women aged 40 years and older.

Authors:  Saleh M M Rahman; Mark B Dignan; Brent J Shelton
Journal:  Ethn Dis       Date:  2003       Impact factor: 1.847

9.  BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.

Authors:  Katie L Stone; Dana G Seeley; Li-Yung Lui; Jane A Cauley; Kristine Ensrud; Warren S Browner; Michael C Nevitt; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2003-11       Impact factor: 6.741

10.  Nonadherence and osteoporosis treatment preferences of older women: a qualitative study.

Authors:  C G Unson; E Siccion; J Gaztambide; S Gaztambide; P Mahoney Trella; K Prestwood
Journal:  J Womens Health (Larchmt)       Date:  2003-12       Impact factor: 2.681

View more
  5 in total

Review 1.  Osteoporosis prevention, screening, and treatment: a review.

Authors:  Juliana M Kling; Bart L Clarke; Nicole P Sandhu
Journal:  J Womens Health (Larchmt)       Date:  2014-04-25       Impact factor: 2.681

2.  Access to oral osteoporosis drugs among female Medicare Part D beneficiaries.

Authors:  Chia-Wei Lin; Pinar Karaca-Mandic; Jeffrey S McCullough; Lesley Weaver
Journal:  Womens Health Issues       Date:  2014-05-14

3.  Engineering of L-Plastin Peptide-Loaded Biodegradable Nanoparticles for Sustained Delivery and Suppression of Osteoclast Function In Vitro.

Authors:  Sunipa Majumdar; Aniket S Wadajkar; Hanan Aljohani; Mark A Reynolds; Anthony J Kim; Meenakshi Chellaiah
Journal:  Int J Cell Biol       Date:  2019-05-05

4.  New Model for Osteoporosis Risk Screening Using Emergency Department Visits.

Authors:  Andrew Alabd; Andre Alabd; Matthew Miller; Carrie Walsh; Alex Silverman; Nooreen Dabbish; Chol Kuoiloi; Stanton Miller
Journal:  Cureus       Date:  2022-02-15

5.  Toxoplasma gondii infection as a risk factor for osteoporosis: a case-control study.

Authors:  Kehui Zhu; Kun Liu; Junsi Huang; Xueqiong Weng; Qiaoyun Chen; Tianyu Gao; Kebing Chen; Chunxia Jing; Jing Wang; Guang Yang
Journal:  Parasit Vectors       Date:  2022-04-27       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.